MedTrace Logo

Lymphoproliferative Disorders After Diagnosis of Childhood Acute Lymphoblastic Leukemia/Lymphoma

NCT04055558 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-10-01

No results posted yet for this study

Summary

Lymphoproliferative disorders (LPD) are a major cause of morbidity and mortality in immunodeficient patients. There have been isolated case reports of patients with childhood ALL who developed LPD after ALL diagnosis, without undergoing stem cell transplantation, but data regarding such cases are limited. We propose here an international collaboration, to form a comprehensive database of children who developed LPD after diagnosis of acute lymphoblastic leukemia/lymphoma

Conditions

  • Childhood Leukemia and Lymphoma

Sponsors & Collaborators

  • Israeli Society for Pediatric Hematology-Oncology

    collaborator OTHER

  • International BFM Study Group

    collaborator NETWORK

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Sarah Elitzur, MD · Schneider Children's Medical Center

Eligibility

Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-25
Primary Completion
2021-12-18
Completion
2022-03-18

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04055558 on ClinicalTrials.gov